Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
HRT associated with higher relative risk of lobular and tubular breast cancers
March 16th, 2006
Estrogen-progestin menopausal hormone therapy is associated with a more than two-fold higher relative risk of developing lobular cancer or tubular cancer than of developing ductal cancer, according to a large European study. Data show combination hormone replacement therapy (HRT) is associated with a higher relative risk of developing tubular cancer than ductal cancer, when taken for more than five years, and also confirm previous findings of HRT's association with a higher relative risk of lobular cancer than ductal cancer. The findings were reported in the February 17, 2006, issue of Breast Cancer Research (Breast Cancer Res, 2006;8:R11;...
Source: Women's Health Weekly (2006-03-16)
|
